Clinical trial
Switching Medication to Treat Schizophrenia
NCT00044655 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00044655 |
|---|---|
| Title | Switching Medication to Treat Schizophrenia |
| Official title | Effectiveness of Switching Antipsychotic Medications |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone, Olanzapine, Ziprasidone, Quetiapine, Aripiprazole |
| Enrollment | 219 |
| Start date | Jul 1, 2001 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 5, 2002 |
| Last update posted | Apr 28, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: